Introduction Genetic analyses of idiopathic hypogonadotropic hypogonad- ism (IHH), an important human disease model with implications  for the discovery of genes responsible for human puberty, have  provided considerable insight into the genes that control sexual  maturation. IHH is a clinically and genetically heterogenous dis- order resulting in gonadotropin-releasing hormone (GnRH) defi- ciency that can be inherited as an X-linked, autosomal recessive,  or autosomal dominant trait. IHH has been considered to be a  monogenic disorder with several loci identified to date: Kallmann  syndrome 1 sequence (KAL1) (1–3), FGF receptor 1 (FGFR1) (4), proki- neticin 2 (PROK2), and prokineticin receptor 2 (PROKR2) (5) under- lie cases of Kallmann syndrome (KS), while gonadotropin-releasing  hormone receptor (GNRHR) (6), FGFR1 (7), and G protein–coupled  receptor 54 (GPR54) (8, 9) underlie normosmic IHH (nIHH). Addi- tionally, nasal embryonic LHRH factor (NELF) has been implicated in  the pathogenesis of KS (10). Despite these advances, conundrums  remain in understanding the genetic basis of IHH. For example,  there is a puzzling clinical heterogeneity of the reproductive and  Nonstandard	abbreviations	used: D3, immunoglobulin-like domain 3; FGFR1, FGF  receptor 1; GnRH, gonadotropin-releasing hormone; GNRHR, gonadotropin-releasing  hormone receptor; IHH, idiopathic hypogonadotropic hypogonadism; KAL1, Kall- mann syndrome 1 sequence; KS, Kallmann syndrome; NELF, nasal embryonic LHRH  factor; nIHH, normosmic IHH; SPR, surface plasmon resonance; T, testosterone Conflict	of	interest: The authors have declared that no conflict of interest exists Citation	for	this	article: J.
Clin.Invest. 117:457–463 (2007). doi:10.1172/JCI29884 nonreproductive phenotypes both within and across IHH families  carrying identical single gene mutations (4, 6, 11–14). Therefore,  a given genotype at a single locus cannot reliably predict the phe- notypic manifestations in any given member of affected families.  Additionally, some mutations in genes accounting for IHH, espe- cially FGFR1, apparently demonstrate incomplete penetrance (4).  Finally, defects in the identified genetic loci account for only a  small percentage (<30%) of cases. Thus, it is likely that other major  IHH loci remain to be discovered and/or that the remaining (>70%)  cases are caused by the interplay of several contributing genes We hypothesized that IHH often involves defects in more than 1  gene. Herein we report evidence of IHH caused by the interaction  of 2-gene defects (FGFR1 and NELF in pedigree 1 and GNRHR and  FGFR1 in pedigree 2). In addition, in vitro biochemical character- ization of FGFR1 and NELF mutants is provided Results Pedigree 1. Pedigree 1 has several affected members (Figure 1). The  proband (no. 1-03) was referred to an endocrinologist at age 21 for  failure to undergo puberty. His presentation was consistent with a  severe KS phenotype. He was unvirilized, had eunuchoidal propor- tions (height, 176 cm; span, 185 cm), bilateral gynecomastia, micro- phallus, prepubertal testes (2 ml; normal, >12 ml), a repaired cleft  lip/palate, and clinodactyly. His serum gonadotropin levels were  undetectable, testosterone (T) was 1 nmol/l, and inhibin B 74 pg/ml;   otherwise, he had normal pituitary function and brain imaging.   	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 117      Number 2      February 2007  457 Figure 1 Identification  of  FGFR1  (p.L342S)  and  NELF  (8-bp  intronic  deletion)  mutations in pedigree 1; identification  of GNRHR [p.Q106R] and [p.R262Q]  and FGFR1 (p.R470L) mutations in  pedigree 2.
Only subjects harboring 2  gene defects have IHH.
Probands are  identified by arrows; circles denote  females, squares denote males.
Del,  NELF intronic deletion groove of D3 and is extensively engaged by FGF8b (18) (Figure 3G).  This leucine accounts for the unique binding specificity of FGF8b  for the “c” isoforms of FGFR1–3. Consistent with these structural  data, surface plasmon resonance (SPR) analysis revealed a dramatic  loss (20-fold) in the affinity of the L342S mutant for FGF8b (Figure  3, C and F), with only a small decrease (2-fold) in affinity for FGF1  (Figure 3, A and D) and (3-fold) FGF2 (Figure 3, B and E) L342S FGFR1c missense mutation is a loss-of-function mutation. L6 myo- blasts transiently expressing WT FGFR1c were treated with FGF8b,  which induced a 6-fold increase in LUC reporter gene expression (Fig- ure 3H). In agreement with SPR results, the L342S FGFR1c was silent  when expressed alone. As the KS subject harbored a heterozygous  L342S mutation, we further coexpressed the WT FGFR1 and L342S  in 1:1 and 1:2 ratios. The results are compatible with the hypothesis  that this mutant acts as a dominant-negative mutation The variable degree of sexual maturation among family mem- bers carrying the same FGFR1 mutation led to further candidate  research article Formal testing revealed hyposmia (score of 29/40, below fifth percen- tile for his age) (15). Two subsequent years of gonadotropin therapy  induced full virilization and sperm production. His father (no. 1-01)  had a history of delayed puberty (growth spurt and full virilization  after age 17) and congenital anosmia (score of 13/40), and his adult  serum T was 18.1 nmol/l. The proband’s mother (no. 1-02) had clino- dactyly and Duane ocular retraction syndrome and was menopausal.  The proband’s sister (no. 1-05) exhibited midline defects, including  a bifid nose and high arched palate; the brother (no. 1-04) exhibited  clinodactyly only. The mother and both siblings had normal puberty  and a normal sense of smell as determined by formal testing Mutational analysis of the FGFR1 gene. The proband (no. 1-03) car- ries a unique heterozygous mutation (c.1025 T→C) in exon 7 pre- dicted to substitute a leucine for serine at position 342 (p.L342S)  in the immunoglobulin-like domain 3 (D3) of FGFR1 (Figure 1,  Figure 2, A and B, and Figure 3G). This change was also found  in the affected father (no. 1-01) and the affected sister (no. 1-05)  (Figure 1) but not in 200 white controls Structural and biochemical analysis of the L342S mutation impli- cate a loss of FGF8b signaling through FGFR1c in the pathology of  KS/IHH. The isoforms FGFR1b and FGFR1c are generated  by alternative splicing of exons 8A and 8B, respectively  (16). To date, FGFR1 mutations causing IHH have only  been identified in exon 8B (17), implicating FGFR1c in the  pathogenesis of IHH. Because L342 is highly conserved  among the “c” splice isoforms of FGFR1–3 across species  (Figure 2B), we used the FGFR2c-FGF8b crystallography  model (18) to study L342S. The corresponding amino acid  in FGFR2c, L343, is a key constituent in the hydrophobic  Figure 2 Schematic showing location of the 2 FGFR1 mutations and  conservation of L342 and R470 residues across species and  FGFRs.
(A) The FGFR1 gene is located on chromosome 8p FGFR1 contains 18 exons with intervening introns not drawn  due to scale.
SP, signal peptide; TM, transmembrane domain;  TK, tyrosine kinase domain.
(B) Comparison of L342 and R470  across species and within the FGFR family 458	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 117      Number 2      February 2007 research article Figure 3 The L342S mutation dramatically reduces affinity of FGFR1c for FGF8b, implicating decreased FGF8b/FGFR1c signaling in the etiology of  KS/IHH.
(A–F) The L342S mutation reduces the affinity of FGFR1c for FGF8b.Varying concentrations of WT (A–C) or L342S FGFR1c mutant  (D–F) were injected over a CM5 chip onto which FGF1 (A and D), FGF2 (B and E), and FGF8b (C and F) were immobilized.
Analyte concentra- tions are indicated as follows: 31.25 nM in gray, 62.5 nM in violet, 125 nM in green, 250 nM in red, 500 nM in blue.
(G) The location of L343 in  FGFR2c, the residue corresponding to L342 in FGFR1c, is mapped onto the FGF8b-FGFR2c structure (18).
The L342S mutation should weaken  key hydrophobic contacts between F32, V36, and F93 of FGF8b and D3 of FGFR.
Gray: molecular surface of FGFR; orange: FGF8b.The side  chains of selected residues are shown.
The molecular surface of the hydrophobic groove of FGFR D3 (yellow) is rendered transparent so that  the side chain of L343 (the residue corresponding to L342 of FGFR1c) is visible.
(H) L342S FGFR1 heterozygous mutation is a loss-of-function  mutation.
WT and L342S FGFR1c were transiently transfected into L6 myoblasts with an FGFR1-responsive osteocalcin promoter luciferase  construct.
FGF8b treatment of WT FGFR1c induced a 6-fold increase in LUC reporter gene expression, while the L342S FGFR1c alone remained  silent.
The coexpression of the WT and L342S FGFR1c suggests that this mutation acts as a dominant negative gene screening and the identification of an additional deletion in  NELF in the severely affected proband Mutational analysis of the NELF gene. A heterozygous 8-bp deletion  ending 14 bp before exon 10 (c.1159-14_-22del) was identified in the  proband (no. 1-03), his mother (no. 1-02), and his brother (no. 1-04)  (Figure 4A). This deletion was not observed in 384 white controls RT-PCR. The HEK-293 cells transfected with the WT plasmid  expressed NELF exons 8–11 at the expected size (291 bp). However,  cells transfected with the 8-bp intronic deletion plasmid expressed  an additional 257-bp splice form of NELF mRNA, lacking exon  10 (Figure 4C). The missplicing of mRNA lacking exon 10 results  in a premature stop codon that predicts a truncated NELF pro- tein product (p.Y376X) rather than the full-length product, which  comprises 528 residues Immunohistology of FNC-C4 cells. Colocalization of both NELF and  GnRH1 in FNC-B4 cells was demonstrated by immunohistochemistry  (Figure 4D) and RT-PCR (data not shown) Genotype-phenotype correlations. Proband no. 1-03 exhibited a  severe KS phenotype with absent puberty, microphallus, hyposmia,  undetectable serum luteinizing hormone and follicle stimulating  hormone levels, hypogonadal T levels, and low inhibin B levels. He  also had clinodactyly and cleft lip and palate. He harbored both a  paternally derived heterozygous FGFR1 mutation (c.1025 T→C,  p.L342S), resulting in weaker binding to FGF8b, and a maternally  derived heterozygous 8-bp intronic deletion of NELF, resulting in  a splicing defect of exon 10 and premature stop codon (Figures  1–4). While a single gene defect was associated with an attenuated  phenotype (i.e., delayed puberty and anosmia in the father carrying  L342S only), 2 mutant genes/gene products (FGFR1 and NELF)  synergized to produce a more severe KS phenotype Pedigree 2. All members of the second, previously reported (14)  pedigree were normosmic by formal smell testing, including 2 sis- ters affected with nIHH (Figure 1). The proband (no. 2-03) present- ed at 17 with primary amenorrhea, no breast development, short  fourth metacarpals, and osteoporosis. She had undetectable serum  gonadotropin and estradiol (E2) levels but otherwise normal pitu- itary function and cranial imaging. As previously reported, pulsatile  GnRH induced ovulation in the proband, but she had 5 consecutive  miscarriages (14). Her sister also presented at 18 with primary amen- orrhea, absent breast development, and scoliosis. She had 2 success- 	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 117      Number 2      February 2007  459 research article Figure 4 A 8-bp intronic NELF deletion results in missplicing of exon 10.
(A) Direct DNA sequencing of  cloned PCR products of the proband’s genomic DNA revealed a heterozygous 8-bp deletion  in intron 9.
This deletion is part of a direct 8-bp repeat (tgtggcct) and occurs 14 bp upstream  of the exon 10 acceptor (5′) splice site.
The lower case part of the sequence indicates introns  while the upper case indicates exons.
(B) Predicted cDNAs in the exon 8–11 region of the  NELF gene.
The proband was found to have an 8-bp deletion in intron 9 (black triangle), 14  bp upstream of exon 10.
(C) The result of RT-PCR using HEK-293 cell mRNA from cells  transfected with WT NELF genomic construct containing exons 8–11 and the mutant NELF  construct (8-bp deletion in intron 9).
The HEK-293 cells transfected with the WT NELF con- struct show a normally spliced NELF exon 8–11 RT-PCR product, corresponding to the pre- dicted size of 291 bp.
The cells transfected with the mutant NELF construct, however, show  an additional band of 257 bp corresponding to the expected size of a transcript lacking exon  10.
The RNA from cells transfected with either WT or mutant genomic construct show an  additional product of 794 bp (786 bp for the mutant construct), reflecting PCR amplification of  the residual plasmid DNA.
(D) Colocalization of NELF and GnRH1 in the olfactory epithelial  cell line FNC-B4 by immunohistochemistry.